Pešić Andrej, Vuković Vojin, Kozarac Sofija, Otašević Vladimir, Bibić Tamara, Mihaljević Biljana, Antić Darko
University Clinical Center of Serbia, Clinic for Hematology, Belgrade.
J Med Biochem. 2024 Jun 15;43(4):631-637. doi: 10.5937/jomb0-48290.
Hemophagocytic lymphohistiocytosis (HLH) is a rare, lifethreatening hyperinflammatory disorder characterized by dysfunction of NK cells and cytotoxic lymphocytes. We present a rare case of a patient diagnosed with HLH who presented with persistent fever during treatment for refractory T-cell/histiocyte-rich large B-cell lymphoma (TCHRLBCL), highlighting the challenges of managing HLH in the context of refractory lymphoma. According to our review of the literature, this is the first case of HLH that developed several months into treatment for refractory TCHRLBCL and not in close temporal relation to lymphoma diagnosis.
噬血细胞性淋巴组织细胞增生症(HLH)是一种罕见的、危及生命的高炎症性疾病,其特征为自然杀伤(NK)细胞和细胞毒性淋巴细胞功能障碍。我们报告一例罕见病例,一名被诊断为HLH的患者在治疗难治性富含T细胞/组织细胞的大B细胞淋巴瘤(TCHRLBCL)期间出现持续发热,突出了在难治性淋巴瘤背景下管理HLH的挑战。根据我们对文献的回顾,这是首例在难治性TCHRLBCL治疗数月后发生HLH的病例,而非与淋巴瘤诊断在时间上密切相关。